Metformin, An Antiaging
Drug To Live Up To 120 Years
Metformin is an oral
antidiabetic medication used mainly in the treatment of type 2 diabetes. Its role is to decrease insulin
resistance in the body intolerant to carbohydrate and decrease liver gluconeogenesis, metabolic process by
which an organism produces sugars (namely glucose) for catabolic reactions from non-carbohydrate precursors.
It is used in first-line treatment of type 2 diabetes, alone or in combination with other oral
But There is
More... Metformin Is A Powerful Anti Aging
This pill could extend
life expectancy to 120 years, and it will soon be tested on humans.
According to a team of
researchers from the Buck Institute for Research on Aging, a biomedical research institute located in
California dedicated to research on aging and age-related disease, the drug has already prolonged the life of
laboratory mice to 40% and made their bones denser, which makes Metforminone of the best new anti aging
drugs on the market.
Although this miracle
pill is generally used for the treatment of diabetes, the scientists wanted to test whether it also had the
ability to slow or counteract heart problems or degenerative diseases such as Parkinson's or Alzheimer's. "If
we can slow the aging process, all pathologies associated with aging will slow in stride," said Gordon
Lithgow, PhD. Professor at the Buck Institute for Research on Aging.
Metformin Anti Aging
For scientists, the
ageing process is reversible, the continuous renewal of the body through the DNA chains in the cells being
proven. Metformin appears able, in turn, to increase the oxygen molecules that penetrate into the cells. It
is this phenomenon that allows to substantially increase longevity. Last year, a study conducted at the
Cardiff University, UK, had already shown that the Drug prolonged the life of patients with
The researchers also
believe targeting ageing will make the fight easier in combating cancer. The same researcher, Professor
Lithgow, believes it may soon be possible for young people to be given a type of antiaging ‘vaccine’, which
will have a big impact on curing cancer as well: “If we were to cure all cancers it would only raise life expectancy by
around three years, because something else is coming behind the cancer, but if we could slow down the ageing
process you could dramatically improve how long people can live.”
The US Agency for Food
and Drug Administration (FDA) has already given the green light to start testing Metformin, as a new
antiaging drug, on humans this coming winter of 2016. To this end, scientists will recruit 3000 elderly from
70 to 90 years suffering from major diseases, or likely to develop. The tests should then take between five
and seven years.